Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
Hubert H FernandezJames T BoydVictor S C FungMark F LewRamon L RodriguezJohn T SlevinDavid G StandaertCindy ZadikoffArvydas D VanagunasKrai ChatamraSusan EatonMaurizio F FacherisColeen HallWeining Z RobiesonJanet BeneshAlberto J EspayPublished in: Movement disorders : official journal of the Movement Disorder Society (2018)
This long-term study demonstrates sustained and clinically meaningful benefits from levodopa-carbidopa intestinal gel in advanced PD patients. Although adverse event rates decreased over time, vigilance is required for device-related complications and adverse events. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.